Biocon share price: Shares of Biocon Ltd rose 3% after Biocon Pharma received FDA approvals for cancer drugs Lenalidomide and Dasatinib, enhancing its US oncology market presence. The company also got tentative approval for Rivaroxaban. Despite recent stock declines, analysts suggest a potential 22% upside. Biocon’s Q3 profits dropped sharply due to a previous one-time gain.
Adani Total Gas Q1 Results: Cons PAT down 4% YoY to Rs 165 crore but revenue rises 21%
Adani Total Gas reported a slight dip in Q1 net profit, reaching Rs 165 crore, while revenue surged by 21% to Rs 1,498 crore. Volume